|
Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo
|
23 October 2013 |
|
Human ovarian cancers express somatostatin receptors
|
22 October 2013 |
|
Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status
|
21 October 2013 |
|
Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2
|
20 October 2013 |
|
Physical and functional interactions between protein tyrosine phosphatase alpha, PI 3-kinase, and PKCdelta
|
16 October 2013 |
|
Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system?
|
14 October 2013 |
|
The antitumor somatostatin analogue TT-232 induces cell cycle arrest through PKCdelta and c-Src
|
14 October 2013 |
|
Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction
|
13 October 2013 |
|
Vitamin D and intervention trials in prostate cancer: from theory to therapy
|
10 October 2013 |
|
Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells
|
09 October 2013 |